VGAIT for Chemotherapy-induced Peripheral Neuropathy

Recruiting now · Not applicable

Conditions studied: Chemotherapy-induced Peripheral Neuropathy

In brief

Perform a feasibility study on imagined acupuncture treatment of Chemotherapy-induced peripheral neuropathy (CIPN)

Key facts

Study ID

NCT07177820

Run by

Massachusetts General Hospital

People needed

20

Starts

2026-01-06

Expected to finish

2026-12-31

Last updated by the study team

2026-07-22

Who can join

Age: 18 and older, up to 80. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• at least 18 years of age
• have histologically confirmed stage I-III breast cancer,
• have completed adjuvant taxane-based chemotherapy (alone or in combination), ,
• have an Eastern Cooperative Oncology Group performance status of 0 or 1, and reported grade 1 or greater CIPN symptoms for more than 2 weeks as defined by the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE), version 4.03.

You may not qualify if…

• concurrent chemotherapy (there were no limitations on time from the last paclitaxel administration),
• having metastatic or recurrent disease,
• history of preexisting peripheral neuropathy prior to chemotherapy,
• uncontrolled seizure disorder,
• unstable cardiac disease or myocardial infarction within 6 months prior to study entry, being pregnant or nursing, or having used acupuncture for CIPN within 6 months prior to study entry.

Where it is running

• Massachusetts General Hospital — Charlestown, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.